American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Published on by Alex Senchenkov

Alex Senchenkov, MD, FACS – Bradenton, Florida

Practice Contact Information

Alex Senchenkov, MD, FACS
6310 Health Park Way
Suite 110
Bradenton
Florida
34202
United States

Phone: 5073982753
Email: drsenchenkovpractice@gmail.com
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Alex Senchenkov, MD, completed his medical education with honors in the Ukrainian State Medical University, Kiev, Ukraine in 1993. He subsequently worked at the Kiev Research Institute of Oncology as a staff surgical oncologist prior to immigrating. In the US, Dr Senchenkov worked at John Wayne Cancer Institute, Santa Monica, CA and then completed residency training in Surgery at The Medical College of Ohio, Toledo, OH and Plastic Surgery at Mayo Clinic, Rochester, MN. He subsequently completed fellowships in Microsurgery at the University of Pittsburgh and Head & Neck Surgical Oncology at the University of Cincinnati. Dr. Senchenkov holds active board certifications by the American Board of Surgery and the American Board of Plastic Surgery.

The practice is focused on delivering high-quality, personalized care to the patients with head and neck tumors, thyroid/parathyroid problems, craniofacial deformities, and oncologic microsurgical reconstructive needs. All insurance plans including Medicaids are accepted or negotiated with insurance companies for rates. We serve patients who travel from out-of-state for care.

Clinical Trials

Bibliography

Published on by Miriam Lango

Miriam Lango – Houston, Texas

Practice Contact Information

MD Anderson Cancer Center
1515 Holcombe Boulevard

Houston
Texas
77030
United States

Phone:
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon

Biography/Statement

I was a faculty member at the Fox Chase Cancer Center for 15 years prior to joining MD Anderson Cancer Center in 2019. As a faculty member at comprehensive cancer centers, I believe that multidisciplinary head and neck and endocrine cancer care will yield the best outcomes for patients. My research endeavors have involved functional outcomes and quality of life in head and neck cancer, and health care delivery issues and tumor markers. These endeavors are more fully described below. My research and clinical experience have laid the groundwork for quality of life studies in other tumor types.

Clinical Trials

Bibliography

 

  1. Ebersole B, Lango M, Ridge J, et al. Dysphagia Screening for Pneumonia Prevention in a Cancer Hospital: Results of a Quality/Safety Initiative. Otolaryngol Head Neck Surg. 2019: Dec 3 ePub.
  2. Roldan CS, Chen JJ, Fareed MM, Hameed MY, Churilla TM, Lango MN et al. Impact of primary tumor-specific growth rate on treatment failure for nonropharyngeal head and neck cancers. 2019 ePub.
  3. Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. 2019 Oct 15;125(20):3582-3594.
  4. Dong Y, Ridge JA, Ebersole B, Li T, Lango MN et al. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral oncology. 2019; 95:59-64.
  5. Tang, J and Lango M. Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US. Oral oncology. 2019 Apr; 91:65-68.
  6. Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. Journal of voice : official journal of the Voice Foundation 2018; 32:325-331.
  7. Moten AS, Lango MN, Goel N, Goldberg AJ. Regional diagnostic rates, treatments, and outcomes among patients with invasive ductal carcinoma. The Journal of surgical research 2018; 229:114-121.
  8. Zuniga SA, Lango MN. Effect of rural and urban geography on larynx cancer incidence and survival.Laryngoscope. 2018 Aug;128(8):1874-1880.
  9. Dong Y, Ridge JA, Li T, Lango M, et al. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer. Oral oncology 2017; 71:122-128.
  10. Ebersole B, Soni RS, Moran K, Lango M et al. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. Journal of voice : official journal of the Voice Foundation2018 May;32(3):325-331.
  11. Wang LS, Handorf EA, Ridge JA, Burtness B, Lango M et al. Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification. Ear, nose, & throat journal 2017; 96:E12-e18.
  12. Liu JC, Sopka DS, Mehra R, Lango M et al. Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence. World J Otorhinolaryngol Head Neck Surg 2016; 2:193-197.
  13. Smith A, Handorf E, Arjmand E, Lango MN. Predictors of regional Medicare expenditures for otolaryngology physician services. 2017;127(6):1312-1317.
  14. Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN et al. EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer. Mol Cancer Ther. 2016 Oct: 15 (10): 2486-2497.
  15. Lango MN, Handorf E, Arjmand E. The geographic distribution of the otolaryngology workforce in the United States. Laryngoscope 2016 Oct 24.
  16. Koshkareva Y, Liu JC, Lango M, Galloway T, Gaughan JP, Ridge JA. Cervical metastases in squamous cell carcinoma of the hard palate and maxillary alveolus. Ear Nose Throat J. 2016 Oct-Nov;95(10-11):E6-E11.
  17. Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN, et al. EGFR and RB1 as dual markers in HPV-negative head and neck cancer. Mol Cancer Ther. 2016 Oct;15(10):2486-2497.
  18. Azadarmaki R, Then MT, Walia R, Lango MN. Cavernous hemangioma of the submandibular gland with parapharyngeal extension in an adult: Case report. Ear Nose Throat J. 2016 Feb;95(2):E11-3.
  19. Lango MN, Galloway T, Mehra R, Ebersole B, Liu J, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head Neck. 2016 Apr;38 Suppl 1:E1318-24.
  20. Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck. Oncotarget 2015 Aug 7;6(22):18863-74.
  21. Aaron H, Azadarmaki R, Lango MN. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review. Am J Ther. 2016 Mar-Apr;23(2):e621-3.
  22. Patel SA, Abdollahi H, Ridge JA, Chang EI, Lango MN, Topham NS. Asymptomatic Deep Peroneal Vein Thrombosis During Free Fibula Flap Harvest: A Review of the Literature, Strategies for Preoperative Assessment, and an Algorithm for Reconstruction. Ann Plast Surg. 2016 Apr;76(4):468-71.
  23. Lango MN, Galloway T, Mehra R, Ebersole B, Liu J, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head Neck. 2016 Apr;38 Suppl 1:E1318-24.
  24. Cracchiolo J, Ridge JA, Egleston B, Lango M. Practice arrangement and Medicare physician payment in otolaryngology. Otolaryngol Head Neck Surg. 2015 Jun;152(6):979-87.
  25. Arrangoiz R, Galloway TJ, Papavasiliou P, Ridge JA, Lango MN. Metastatic cervical carcinoma from an unknown primary: literature review. Ear Nose Throat J. 2014 Apr-May;93(4-5):E1-10. Review.
  26. Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. 2014 Mar 15;120(6):840-7.
  27. Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu Z, Alpaugh RK, Lango MN, Yu JQ. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. J Nucl Med. 2013 Dec;54(12):2087-92.
  28. Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head Neck. 2014 Dec;36(12):1677-84.
  29. Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova AS, Golemis EA, Flieder DB, Cooper HS, Lango M, Ridge JA, Burtness B. Quantification of excision  repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers. Clin Cancer Res. 2013 Dec 1;19(23):6633-43.
  30. Sopka DM, Li T, Lango MN, Mehra R, Liu JC, Burtness B, Flieder DB, Ridge JA, Galloway TJ. Dysplasia at the margin? Investigating the case for subsequent therapy in ‘low-risk’ squamous cell carcinoma of the oral tongue. Oral Oncol. 2013 Nov;49(11):1083-7.
  31. Fang CY, Egleston BL, Ridge JA, Lango MN, Bovbjerg DH, Studts JL, Burtness BA, Einarson MB, Klein-Szanto AJ. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. Head Neck. 2014 Aug;36(8):1113-9.
  32. Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, Burtness B, Mehra R, Galloway T, Ridge JA. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. 2013 Sep;23(9):1099-105.
  33. Fang CY, Longacre ML, Manne SL, Ridge JA, Lango MN, Burtness BA. Informational Needs of Head and Neck Cancer Patients. Health Technol (Berl). 2012 Apr 1;2(1):57-62.
  34. Galloway TJ, Lango MN, Burtness B, Mehra R, Ruth K, Ridge JA. Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns. Head 2013 Feb;35(2):160-4.
  35. Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck. 2011 Oct;33(10):1433-40.
  36. Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol. 2010 Dec;33(6):599-603.
  37. Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):65-70.
  38. Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen C. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1020-5.
  39. Lango MN, Egleston B, Ende K, Feigenberg S, D’Ambrosio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010 Mar;32(3):341-7.
  40. Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009 Mar;31(3):328-37.
  41. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res. 2006 Sep 1;12(17):5064-73.
  42. Lango M, Wentzel AL, Song JI, Xi S, Johnson DE, Lamph WW, Miller L, Grandis JR. Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res. 2003 Sep 15;9(11):4205-13.
  43. Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 2002 Mar 6;94(5):375-83.
  44. Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines. Cancer Res. 2001 Aug 1;61(15):5919-25.
  45. Shah SI, Yip L, Greenberg B, Califano JA, Chow J, Eisenberger CF, Lee DJ, Sewell DA, Reed AL, Lango M, Jen J, Koch WM, Sidransky D. Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2000 Sep;126(9):1073-6.
  46. Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo. Gene Ther.2000 Nov;7(22):1906-14.
  47. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. 1999 Oct;109(10):1544-51.
  48. Donohue TJ, Dworkin LD, Ma J, Lango MN, Catanese VM. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. J Investig Med. 1997 Dec;45(9):584-91.
  49. Linn JF, Lango M, Halachmi S, Schoenberg MP, Sidransky D. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer. 1997 Dec 19;74(6):625-9.
  50. Lee DJ, Koch WM, Yoo G, Lango M, Reed A, Califano J, Brennan JA, Westra WH, Zahurak M, Sidransky D. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res.1997 Apr;3(4):501-5.
  51. Califano JA, Johns MM 3rd, Westra WH, Lango MN, Eisele D, Saji M, Zeiger MA, Udelsman R, Koch WM, Sidransky D. An allelotype of papillary thyroid cancer. Int J Cancer. 1996 Dec 20;69(6):442-4.
  52. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. 1994 Feb;89(2):799-809.
  53. Catanese VM, Sciavolino PJ, Lango MN. Discordant, organ-specific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats. 1993 Feb;132(2):496-503.

Published on by Wael Hasan

Wael Hasan – Toronto, Ontario

Practice Contact Information

Toronto General Hospital
200 Elizabeth Street – Office # 8NU 880

Toronto
Ontario
M5G 2C4
Canada

Phone:
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Graduated from the Royal College of Surgeons of Ireland (2004)

Awarded Membership of the Royal College of Surgeons of Ireland (2009)

Basic Surgical Training of the Royal College of Surgeons of Ireland (2009)

Awarded the Degree of Master of Surgery (MCh) by University College Dublin – National University of Ireland (2014)

Higher Surgical Training Program in Otolaryngology – Head & Neck Surgery of the Royal College of Surgeons of Ireland (2016)

Fellowship in Advanced Training in Head & Neck Oncological Surgery – University of Toronto, Canada

Clinical Trials

Bibliography

Published on by Masahiro Kikuchi

Masahiro Kikuchi – Kyoto, Kyoto

Practice Contact Information

Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University
54 Shogoin Kawahara-cho, Sakyo-ku,

Kyoto
Kyoto
606-8507
Japan

Phone:
Email: m_kikuchi@ent.kuhp.kyoto-u.ac.jp
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Oral Surgeon

Biography/Statement

Academic and Hospital Appointments:

2018-Present   Assistant Professor, Graduate School of Medicine, Kyoto University

2017-2018       Director of Head and Neck Surgery, Kobe City Medical Center General Hospital, Kobe

2015-2017       Visiting Scholar, Pittsburgh University Cancer Institute, Pittsburgh, USA

2013-2015       Director of Head and Neck Surgery, Kobe City Medical Center General Hospital, Kobe

2006-2013       Deputy Head of Head and Neck Surgery, Kobe City Medical Center General Hospital, Kobe

2001-2006       Physician, Kobe City General Hospital, Kobe

Residencies:

1999-2000     Kyoto University Hospital, Kyoto

2000-2001     Takatsuki Red Cross Hospital, Osaka

Awards and Honors:

2009: Poster of Distinction in American Head and Neck Society 2009 during Combined Otolaryngological Spring Meetings

2012: Hisada Prize in Annals of Nuclear Medicine

2016: Poster of Distinction in American Head and Neck Society 2009 during Combined Otolaryngological Spring Meetings in Phoenix

 

Major Clinical Interest

head and neck surgery

endoscopic endonasal skull base surgery

maxillofacial surgery

thyroid cancer surgery

PET imaging

Immunotherapy

Clinical Trials

Bibliography

Original Article

  1. Kikuchi M, Funabiki K, Hasebe S, Takahashi H. Cerebellar arteriovenous malformation with facial paralysis, hearing loss, and tinnitus: A case report. Otol Neurotol 23: 723-726, 2002
  2. Kikuchi M, Yamamoto E, Shiomi Y, Nakamoto Y, Shiomi Y, Fujiwara K, Watanabe F, and Shinohara S. Internal and external jugular vein thrombosis with marked accumulation of FDG. BJR 77: 888-890, 2004.
  3. Fujiwara K, Naito Y, Senda M, Mori T, Manabe T, Shinohara S, Kikuchi M, Hori S, Tona Y, Yamazaki H. Brain metabolism of children with profound deafness: a visual language activation study by 18F-fluorodeoxyglucose positron emission tomography. Acta Otol 128: 393-397, 2008.
  4. Kikuchi M, Naito Y, Senda M, Okada T, Shinohara S, Fujiwara K, Hori SY, Tona Y, Yamazaki H. Cortical activation during optokinetic stimulation-an fMRI study. Acta Oto-Laryngologica 129: 440-443, 2009.
  5. Shinohara S, Kikuchi M, Naito Y, Fujiwara K, Hori S, Tona Y, Yamazaki H, Kobayashi H, Ishihara T. Successful treatment of locally advanced anaplastic thyroid carcinoma by chemotherapy and hyperfractionated radiotherapy. Auris Nasus Larynx 36:  729-732, 2009.
  6. Kosaka Y, Okuno Y, Tagawa Y, Ueki N, Itoh K, Shinohara S, Kikuchi M Osteoradionecrosis of the cervical vertebrae in patients irradiated for head and neck cancers.

Jpn J Radiol 28: 388-394, 2010.

  1. Kikuchi M, Shinohara S, Nakamoto Y, Usami Y, Fujiwara K, Adachi T, Hori SY, Tona Y, Yamazaki H, Imai Y, Naito Y. Sequential FDG-PET/CT after Neoadjuvant Chemotherapy is a Predictor of Histopathologic Response in Patients with Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol 13: 368-377, 2011.
  2. Kikuchi M, Yamane T, Shinohara S, Fujiwara K, Hori SY, Tona Y, Yamazaki H, Naito Y, Senda M. 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma. Ann Nucl Med 25: 625-633, 2011.
  3. Yamane T, Kikuchi M, Shinohara S, and Senda M. Reduction of　18F-fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma.

Mol Imaging Biol 13: 227-231, 2011.

  1. Kikuchi M, Nakamoto Y, Shinohara S, Fujiwara K, Tona Y, Yamazaki H, Kanazawa Y, Kurihara R, Imai Y, Naito Y. Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery. Auris Nasus Larynx 39:94-97, 2012
  2. Yamazaki H, Fujiwara K, Shinohara S, Kikuchi M, Kanazawa Y, Kurihara R, Kishimoto I, Naito Y. Reversible cochlear disorders with normal vestibular functions in three cases with Wegener’s granulomatosis. Auris Nasus Larynx. 39:236-40,2012.
  3. Kikuchi M, Nakamoto Y, Shinohara S, Fujiwara K, Yamazaki H, Kanazawa Y, Kurihara R, Kishimoto I, Harada H, Naito Y. Early Evaluation of Neoadjuvant Chemotherapy Response using FDG-PET/CT Predicts Survival Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Int J Clin Oncol. 18: 402-410, 2013.
  4. Kishimoto I, Yamazaki H, Naito Y, Shinohara S, Fujiwara K, Kikuchi M, , Kanazawa Y, Tona R, Harada H. Clinical features of rapidly progressive bilateral sensorineural hearing loss. Acta Otolaryngol. 134: 58-65, 2014.
  5. Yamazaki H,Kikuchi M, Shinohara S, Naito Y, Fujiwara K, Kanazawa Y, Tona R. Intra-arterial administration of antibiotics for refractory skull base osteomyelitis. Auris Nasus Larynx 41:380-383, 2014.
  6. Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K, Hayashida K, Itoh K, Togashi K. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. AJR Am J Roentgenol. 202: 851-858, 2014.
  7. ShinoharaS, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, Imai Y, Usami Y. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.

Jpn J Clin Oncol. 44: 232-240, 2014.

  1. Tona R, Shinohara S, Fujiwara K, Kikuchi M, , Kanazawa Y, Kishimoto I, Harada H, Naito Y.

Risk factors for retropharyngeal cellulitis in Kawasaki disease. Auris Nasus Larynx. 41:455-8, 2014

  1. Kanazawa Y, Naito Y, Tona R, Fujiwara K, Shinihara S, Kikuchi M, Yamazaki H, Kishimoto I, Harada H. Predictive value of middle ear aeration before second-stage operation in staged tympanoplasty with soft-wall reconstruction.Acta Otolaryngol. 134:135-9, 2014
  2. Shinohara S, Kikuchi M, Tona R, Kishimoto I, Harada H, Shimeno N: Eleven synchronous/metachronous primary carcinomas of the upper gastrointestinal tract: a case report. Case Reports in Clinical Pathology, 2014, Vol. 1, No. 2.  doi: 10.5430/crcp.v1n2p159
  3. Kikuchi M, Koyasu S, Shinohara S, Usami Y, Imai Y, Hino M, Itoh K, Tona R, Kanazawa Y, Kishimoto I, Harada H, Naito Y. Prognostic value of pretreatment 18 F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Head Neck. 37:1524-31, 2015
  4. Shinohara S,Kikuchi M, Suehiro A, Kishimoto I, Harada H. Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer? Acta Otolaryngol. 135:181-6.2015.
  5. Shinohara S, Kikuchi M, Suehiro A, Kishimoto I, Harada H, Hino M, Ishihara T. Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma. Jpn J Clin Oncol. 45:427-32. 2015
  6. Kikuchi M, Shinohara S, Hino M, Itoh K, Tona R, Kishimoto I, Harada H, Fujiwara K, Suehiro A, Naito Y. Detection of subclinical recurrence or second primary cancer using 18F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma Head Neck. Suppl 1:E511-8. 2016
  7. Tona R, Naito Y, Moroto S, Yamamoto R, Fujiwara K, Yamazaki H, Shinohara S, Kikuchi M. Audio-visual integration during speech perception in prelinguallydeafened Japanese children revealed by the McGurk effect. Int J Pediatr Otorhinolaryngol. 79; 12: 2072-78, 2015.
  8. Kishimoto I, Kikuchi M, Shinohara S, Fujiwara K, Kanazawa Y, Tona R, Harada H, Usami Y, Naito Y. A case of angiosarcoma arising from internal jugular vein. Auris Nasus Larynx. 42:68-71,2015.
  9. Kishimoto I, Moroto S, Fujiwara K, Harada H,Kikuchi M, Suehiro A, Shinohara S, Naito Y. Bilateral duplication of the internal auditory canal: a case with successful cochlear implantation. Int J Pediatr Otorhinolaryngol.79:1595-8.2015
  10. Harada H, Shinohara S, Kikuchi M, Fujiwara K, Suehiro A, Kishimoto I, Kuwata F, YamamotoR, Hayashi K, Imai H, Naito Y Multinodular adult rhabdomyoma in the base of the tongue excised conservatively using submental midline approach with hyoid bone split: A case report Case Reports in Clinical Pathology 2: 4, 89-93, 2015.
  11. Kikuchi M, Koyasu S, Shinohara S, Imai Y, Hino M, Naito Y: Preoperative diagnostic strategy for parotid gland tumors using diffusion-weighted MRI and technetium-99m pertechnetate scintigraphy: A prospective study. PLoS One. 2016 Feb 5;11(2):e0148973. doi: 10.1371/journal.pone.0148973. eCollection 2016
  12. Shinohara S, Suehiro A, Kikuchi M, Harada H, Kishimoto I, Imai Y: A case of desmoid tumor co-existing with recurrent squamous cell carcinoma in the larynx. Auris Nasus Larynx [Epub ahead of print]
  13. Shinohara S, Kikuchi M, Harada H, Takebayashi S, Yunoki K, Yamazaki K: The influence of American Society of Anesthesiologists Physical Status on patient morbidity and survival after total thyroidectomy. Endocrine Journal Aug 2016 ·[Epub ahead of print]
  14. Kikuchi M, Clump DA, Srivastava RM, Sun L, Zeng D, Diaz-Perez JA, Anderson CJ, Edwards WB, Ferris RL: Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma. Oncoimmunology, e1329071, 2017.
  15. Okoshi K, Minami T, Kikuchi M, Tomizawa Y: Musical instrument-associated health issues and their management. Tohoku J Exp Med. 243; 1: 49-56, 2017.
  16. Yamamoto R, Naito Y, Tona R, Tamaya R, Moroto S, Fujiwara K, Shinohara S, Takebayashi S, Kikuchi M, Michida T: Audio-visual speech perception in prelingually deafened Japanese children following sequential bilateral cochlear implantation. International Journal of Pediatric Otorhinolaryngology 102: 160‐168, 2017
  17. Harada H, Shinohara S, Takebayashi S, Kikuchi M, Fujiwara K, Michida T, Yamamoto R, Hayashi K, Saida K, Naito Y.　Facial flushingafter alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract.　Jpn J Clin Oncol. 2017 Dec 1;47(12):1123-1128.
  18. Shinohara S, Takebayashi S, Kikuchi M, Michida T, Hayashi K, Yamamoto R, Saida K, Mizuno K, Fujiwara K, Naito Y.　 Prognosticimpact of incisional or excisional biopsy of cervical lymph node metastases of solid tumors.　Jpn J Clin Oncol. 2018 Jun 1;48(6):529-534
  19. Takebayashi S, Shinohara S, Mizuno K, Saida K, Hayashi　K,　Yamamoto　R,　Michida　T,　Kikuchi　M,　Fujiwara　K,　Naito　　Case　of　pN1b　and　pM1　Papillary　Microcarcinoma of the Thyroid. Int J Pract Otolaryngol. 2018;1:e6-e9.
  20. Hayashi K, Kikuchi M (Corresponding Author), Imai Y, Yamashita D, Hino M, Ito K, Shimizu K, Harada H, Shinohara S. Clinical Value of Fused PET/MRI for Surgical planning in patients with oral/oropharyngeal carcinoma. Laryngoscope. 2019. [Epub ahead of print]
  21. Kuwata F, Kikuchi M (Corresponding Author), Ishikawa M, Tanji M, Sakamoto T, Yamashita M, Matsunaga M, Omori K, Nakagawa T. Long-term olfactory function outcomes after pituitary surgery by endoscopic endonasal transsphenoidal approach. Auris Nasus Larynx. 2019 [Epub ahead of print]

Published on by Michael Farrell

Michael Farrell – KOGARAH, NSW

Practice Contact Information

St George Private Hospital and The St George Hospital
1 South Street
St George Private Hospital
KOGARAH
NSW
2217
Australia

Phone:
Email: accounts@headandneck.com.au
Web Site: https://www.headandneck.com.au

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Speech Pathology

Biography/Statement

Head of Department of ENT Head and Neck Surgery, St George and Sutherland Hospital.

Master of Surgery, Sydney University 2018.

Dr Farrell has been a member of The St George Multidisciplinary Head and Neck Cancer Clinic since 1997.

In 2017 spent an intensive learning period training locally with the robot, before travelling to USA for further training on a 1:1 basis with world renowned robotic surgeon Professor J. Scott Magnuson, in order to gain his accreditation.

As part of this interest in the treatment of head and neck cancer, he is the first surgeon to be accredited for Trans Oral Robotic Surgery at St George Private Hospital and was the first surgeon to successfully treat a patient with this technique at St George.

Clinical Trials

Bibliography